As of November 2024, BioInvent International AB has a market cap of $264.29M. This makes BioInvent International AB the world's 15512th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $104.43M | -14.56% |
2023 | $122.22M | -40.84% |
2022 | $206.60M | -30.63% |
2021 | $297.81M | 0.65% |
2020 | $295.87M | 52.93% |
2019 | $193.47M | -35.58% |
2018 | $300.32M | -8.12% |
2017 | $326.85M | -32.57% |
2016 | $484.74M | -12.52% |
2015 | $554.10M | 57.14% |
2014 | $352.62M | -16.35% |
2013 | $421.54M | 2.73% |
2012 | $410.34M | -78.97% |
2011 | $1.95B | -46.80% |
2010 | $3.67B | 16.93% |
2009 | $3.14B | 71.62% |
2008 | $1.83B | -20.43% |
2007 | $2.30B | 72.22% |
2006 | $1.33B | -11.48% |
2005 | $1.51B | 43.66% |
2004 | $1.05B | -11.65% |
2003 | $1.19B | -17.60% |
2002 | $1.44B | -66.22% |
2001 | $4.26B | - |